Cell Source Inc (CLCS):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Cell Source Inc (CLCS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9436
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cell Source Inc (Cell Source), formerly Ticket to See Inc, is a biotechnology company that offers development of cell therapy treatments based on the management of immune tolerance. The company’s Veto Cells are white blood cells taken from either the patient or a healthy third-party donor and used to prevent post-transplant infections resulting from common viruses that cause post-transplant complications and mortality. It also provides anti-rejection Veto Cell, Veto Cell genetically modified cells for allogeneic treatment and Veto Cell for non-malignant disease. Cell Source’ patented Veto-Cell technology represents a breakthrough in immune system management safe and selective tolerizing of immune response, Anti-rejection Veto Cells enable the selective attenuation of immune system response and others. The company provides revolutionizing transplantation and cancer treatment utilizing immune tolerance technology. Cell Source is headquartered in New York, the US.

Cell Source Inc (CLCS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Cell Source Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cell Source Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cell Source Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cell Source Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Cell Source Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cell Source Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Cell Source Plans to Form Joint Venture 10
Licensing Agreements 11
CellSource Enters into Licensing Agreement with American CryoStem 11
Equity Offering 12
Cell Source Raises USD5 Million in Private Placement of Units 12
Cell Source Inc – Key Competitors 13
Cell Source Inc – Key Employees 14
Cell Source Inc – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Cell Source Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Cell Source Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cell Source Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Cell Source Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cell Source Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Cell Source Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Cell Source Plans to Form Joint Venture 10
CellSource Enters into Licensing Agreement with American CryoStem 11
Cell Source Raises USD5 Million in Private Placement of Units 12
Cell Source Inc, Key Competitors 13
Cell Source Inc, Key Employees 14
Cell Source Inc, Subsidiaries 15

List of Figures
Cell Source Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Cell Source Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Cell Source Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Cell Source Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Cell Source Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Cell Source Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Cell Source Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Cell Source Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Cell Source Inc (CLCS):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Teleplan International NV:企業の戦略的SWOT分析
    Teleplan International NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Alps Alpine Co Ltd (6770):企業の財務・戦略的SWOT分析
    Alps Alpine Co Ltd (6770) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cathedral Energy Services Ltd (CET):企業の財務・戦略的SWOT分析
    Summary Cathedral Energy Services Ltd (Cathedral) is an oil and gas company that provides drilling and completion services. The company's services include horizontal and directional drilling services, flowback and production testing, production testing services, measurement while drilling services a …
  • Groupe Bruxelles Lambert SA:企業の戦略・SWOT・財務分析
    Groupe Bruxelles Lambert SA - Strategy, SWOT and Corporate Finance Report Summary Groupe Bruxelles Lambert SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Bioderm Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bioderm Inc (Bioderm) is a medical equipment company that manufactures designs, and markets hydrocolloid products. The company manufactures hydrocolloid products for urinary management, securement, infection control, and skin protection. Its products include cathgrip, bioplus+, freederm, men …
  • Humana Inc.:企業の戦略・SWOT・財務分析
    Humana Inc. - Strategy, SWOT and Corporate Finance Report Summary Humana Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Avnet, Inc (AVT):企業の戦略的SWOT分析
    Avnet, Inc (AVT) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Avis Budget Group, Inc.:戦略・SWOT・企業財務分析
    Avis Budget Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Avis Budget Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Intracom Holdings S.A. (INTRK):企業の財務・戦略的SWOT分析
    Intracom Holdings S.A. (INTRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Bio-Images Drug Delivery Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Bio-Images Drug Delivery Ltd (BDD) is an independent company that focuses on the development of modified and controlled release oral formulations. The company provides formulation development, troubleshooting, in vitro and in vivo testing and full technology transfer programs. It offers wide …
  • Crisil Ltd (CRISIL):企業の財務・戦略的SWOT分析
    Summary Crisil Ltd (Crisil), a subsidiary of S&P Global Inc is a financial service provider that offers risk management services. The company provides ratings, research and risk and policy advisory services. It offers services such as credit ratings, business school gradings, real estate star rating …
  • Enka Power:企業の戦略的SWOT分析
    Enka Power - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Corning Inc (GLW):企業の財務・戦略的SWOT分析
    Corning Inc (GLW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Standard Chem & Pharm Co Ltd:企業の戦略・SWOT・財務分析
    Standard Chem & Pharm Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Standard Chem & Pharm Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Sinclairs Hotels Limited:企業の戦略・SWOT・財務情報
    Sinclairs Hotels Limited - Strategy, SWOT and Corporate Finance Report Summary Sinclairs Hotels Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Euro India Fresh Foods, Ltd. (EIFFL):企業の財務・戦略的SWOT分析
    Euro India Fresh Foods, Ltd. (EIFFL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Ernst & Young Global Ltd
    Ernst & Young Global Ltd - Strategy, SWOT and Corporate Finance Report Summary Ernst & Young Global Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • CitiPower and Powercor:企業の戦略的SWOT分析
    CitiPower and Powercor - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Arkray Inc:企業の製品パイプライン分析2018
    Summary Arkray Inc (Arkray), formerly KDK Corp is a medical device company that offers diagnostic products. The company offers diagnostic products and equipments for diabetes diagnosis and urinalysis applications. Its products comprise automatic glycohemoglobin analyzer for diabetes, automated analy …
  • Innoviva Inc (INVA):企業の財務・戦略的SWOT分析
    Innoviva Inc (INVA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆